| 重视《中国青光眼指南(2020年)》发布后的推广和评价 |
| |
| 引用本文： | 张纯,王宁利.重视《中国青光眼指南(2020年)》发布后的推广和评价[J].中华眼科杂志,2021(3):161-165. |
| |
| 作者姓名： | 张纯 王宁利 |
| |
| 作者单位： | 北京大学第三医院眼科;首都医科大学附属北京同仁医院北京同仁眼科中心 |
| |
| 基金项目： | 国家自然科学基金(81970798)。 |
| |
| 摘 要： | 青光眼是全球首位不可逆性致盲眼病。《中国青光眼指南(2020年)》(以下简称《指南》)基于我国基本国情,结合了国内外最新研究进展,可为我国青光眼临床诊疗工作提供重要参考和建议。眼科界应对《指南》加大宣传和推广力度,拓展其传播渠道和覆盖范围,以期充分发挥《指南》对临床工作的指导作用;还应注重对《指南》进行质量评价和后效评价,在临床工作中检验《指南》的可靠性和适用性,推动青光眼循证实践;同时应不断积累和反馈证据,以促进《指南》更新和完善,从而构建良好的证据生态系统,以期不断有效助力我国青光眼临床诊疗水平提高。(中华眼科杂志,2021,57:161-165)
|
| 关 键 词： | 青光眼 循证实践 诊疗准则 评价研究 生态系统 |
Paying attention to the promotion and evaluation of Chinese Glaucoma Guidelines(2020)after their release |
| |
| Zhang Chun,Wang Ningli.Paying attention to the promotion and evaluation of Chinese Glaucoma Guidelines(2020)after their release[J].Chinese Journal of Ophthalmology,2021(3):161-165. |
| |
| Authors: | Zhang Chun Wang Ningli |
| |
| Institution: | (Department of Ophthalmology,Peking University Third Hospital,Beijing Key Laboratory of Restoration of Damaged Ocular Nerve,Beijing 100191,China;Beijing Tongren Eye Center,Beijing Tongren Hospital,Capital Medical University,Beijing Institute of Ophthalmology,Beijing Key Laboratory of Ophthalmology&Visual Sciences,Beijing 100730,China) |
| |
| Abstract: | Glaucoma is the leading cause of irreversible blindness worldwide.The Chinese Glaucoma Guidelines(2020)formulated important references and suggestions for the treatment of glaucoma,based on the basic national condition of China and considering the latest global progress.To fulfill their guiding effect on clinical work,publicity and promotion of the Guidelines should be intensified to prompt the communication and application.The ophthalmology specialists should pay attention to the quality assessment and reevaluation of the Guidelines regarding their reliability and applicability in clinical work,and promote the evidence-based practice of glaucoma.Continuous feedbacks from clinical practice would enable timely updates and improvement of the Guidelines,thus building a better evidence ecosystem and constantly optimizing the diagnosis and treatment of glaucoma in China.(Chin J Ophthalmol,2021,57:161-165) |
| |
| Keywords: | Glaucoma Evidence-based practice Practice guideline Evaluation study Ecosystem |
| 本文献已被 维普 等数据库收录！ |
|
